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1 INTRODUCTION 
 
 
 
 
1.1 Transcription factors. 
 
The regulation of tissue- and development-specific expression of eukaryotic genes 
is a fundamentally important process that represents the focus of research for 
numerous molecular biologists. A great deal of attention has been paid to the 
study of transcriptions factors (TFs), key elements in the regulation of gene 
expression that interact with cis-regulatory DNA elements in specific genes. Most 
TFs are classified on the basis of structural motifs that they use to bind to DNA 
(Yang 1998). 
 
1.2 The zinc finger transcription factors family. 
 
The zinc finger motif is an important example of DNA-binding sequence. As the 
name implies, a zinc finger is a finger-shaped fold in a protein that allows it to 
bind to its target. It contains a single zinc atom, which serves as a critical 
structural component of the finger motif. Proteins with zinc finger motifs fall into 
several groups, according to the three-dimensional appearance of their DNA-
binding domain and the amino acids that coordinate the Zn2+-ion. The Cys2-His-
Cys motif is exemplified by the myelin transcription factor I MyTI (Kim et 
Hudson 1992). A second motif that chelates zinc ions with a cluster of 6 cysteins 
(Cys6) characterizes GAL4, a positive regulator of galactose metabolism in 
Saccharomyces cerevisiae (Keegan et al. 1986). The Cys2-Cys2 and the Cys2-His2 
zinc fingers tetrahedrally coordinate a zinc atom within a 30 amino acids 
sequence to form the DNA-binding domain with either 4 cysteins (Cys2-Cys2 
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type) or 2 cysteins and 2 histidines (Cys2-His2 type). They also share the property 
of contacting the major groove of DNA with an α-helix. The transcription factor 
GATA-1 is an example of the Cys2-Cys2 motif and is found at all stages of 
erythroid development in vertebrates (Hannon et al. 1991).  
The Cys2-His2 type of zinc finger motif is characterized by a three-dimensional 
structure made up of two antiparallel β-sheets and an α-helix (Berg 1988), called 
the “recognition helix”, that contacts 3 base pairs (bp) of DNA (Berg and Shi 
1996) via 3 amino acids. The Xenopus laevis transcription factor TFIIIA was the 
first Cys2-His2 zinc finger protein identified (Pelham and Brown, 1980). In the 
completely sequenced Caenorhabditis elegans genome, 138 proteins (0.7% of all 
proteins) contain the Cys2-His2 motif (Clarke and Berg, 1998). In comparison, 
there are 352 (2.6%) Cys2-His2 zinc finger proteins in the genome of Drosophila 
melanogaster (Adams et al., 2000). It has been estimated that: 1% of the human 
genome consists of genes encoding Cys2-His2 type of zinc finger protein (Hoovers 
et al., 1992). This would correspond to between 700 and 1000 genes encoding 
distinct zinc finger proteins (Klug and Schwabe, 1995). 
Commonly, this type of motif is found in repeats, and consequently, fingers with 
different DNA triplet preferences combine to create greater specificity in 
recognizing longer DNA stretches (Klug 1999). 
 
1.3 The Krüppel-Like transcription factors. 
 
A subfamily of the Cys2-His2 -zinc fingers has been named Krüppel-like factors 
(KLFs) based on homology to the Drosophila segmentation gene Krüppel (Preiss 
et al. 1985, Bieker 2001). They possess 3 C-terminal Zinc-fingers spaced by the 
highly conserved HC-link, TGEKPYX (X representing any amino acid), first 
identified in Drosophila (Klug et Schwabe 1995). Additionally, the zinc fingers 
contain the CX2-5CX3F/YX5LX2HX3H (where X is any amino acid)-consensus 
sequence that is also found in TFIIIA (Miller et al. 1985), as well as in members 
of the Sp1 (Kadonaga et al. 1987; Hagen et al. 1992) and early growth response 
proteins (Madden and Rauscher 1993). 
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The Krüppel protein is aptly named because Drosophila embryos homozygous for 
this protein have altered anterior abdominal and thoracic segments, resulting in 
death (Nusslein-Volhard et al., 1980, Preiss et al., 1985). The first mammalian 
Krüppel, erythroid Krüppel-like factor (EKLF/KLF1), was identified in red blood 
cells (Miller et Bieker 1993). This factor was subsequently found to play an 
important role in β-globin gene synthesis and erythrocyte development (Perkins et 
al., 1995, Nuez et al., 1995). Since the initial discovery of EKLF in 1993, a total 
of 17 mammalian Krüppel have been identified and designated based on the 
chronological order of discovery (i.e., KLF1 to -17). All members of the KLF 
family are able to bind to similar DNA sequences, such as the “CACCC” 
sequence or the “GT box”. Indeed as mentioned above, there are three amino 
acids in each zinc finger that contact base-triplets of DNA thus specifying the 
binding. Therefore proteins with conserved amino acids in that region will most 
likely have the same or at least very similar target sequences. Although the zinc 
finger domains are very similar, the non–DNA-binding domains are highly 
divergent. Transcriptional regulation by KLFs is mediated via their identified 
modular activation and repression domains. The zinc fingers of a few family 
members are aligned in figure 1 to show the conservation of DNA-contacting 
amino acids which results in common or very similar target sequences. Among all 
the KLFs, structural and functional considerations have segregated KLF6 and 
KLF7 into a phylogenetically distinct group (Matsumoto et al., 1998). 
 
 
 
 
KLF1 CAHPGCGKSYTKSSHLKAHLRTHTGEKPYACTWEGCGWRFARSDELTRHYRKHTGQRPFRCQLCPRAFSRSDHLALHMKRH 
KLF4 CDYAGCGKTYTKSSHLKAHLRTHTGEKPYHCDWDGCGWKFARSDELTRHYRKHTGHRPFQCQKCDRAFSRSDHLALHMKRH 
KLF5 CDYPGCTKVYTKSSHLKAHLRTHTGEKPYKCTWEGCDWRFARSDELTRHYRKHTGAKPFQCGVCNRSFSRSDHLALHMKRH 
KLF6 CHFNGCRKVYTKSSHLKAHQRTHTGEKPYRCSWEGCEWRFARSDELTRHYRKHTGAKPFKCSHCDRCFSRSDHLALHMKRH 
KLF7 CQFNGCRKVYTKSSHLKAHQRTHTGEKPYKCSWEGCEWRFARSDELTRHYRKHTGAKPFKCNHCDRCFSRSDHLALHMKRH 
 
Figure 1: Amino acid sequence alignment of the zinc finger region of some KLFs. 
Residues conserved among all members are shown in green. The cysteine and histidine residues 
involved in the coordination of zinc are shown in red. The amino acids thought to contact DNA 
are indicated in yellow. 
FINGER 3 FINGER 2 FINGER 1 
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Figure 2 shows binding sites of some Krüppel-like factors and the conserved 
amino acids that make contact with base triplets.  
 
 
 
 
 
 
 
       KLF7 CONSENSUS BINDING MOTIF: 
 
 
FINGER1  FINGER2  FINGER3 
 
KSSHLKA  RSDELTR  RSDHLAL 
   3’ G  G  N  G  N  G  G  G  N 5’ 
 
 
Figure 2: Binding motifs for selected KLFs 
Residues conserved among all members are shown in green. KLF7 consensus motif is given below 
along with the amino acid sequence of the zinc fingers showing in yellow the critical residues that 
directly contact DNA. 
 
 
1.4 The Krüppel-Like Factor 7. 
 
KLF7 was originally identified by RT-PCR performed on RNA from vascular 
endothelial and rat chondrosarcoma cells using degenerate primers that 
correspond to regions in the DNA-binding domain of KLF1 (Matsumoto et al., 
1998). The human (h) and mouse (m) KLF7 proteins are virtually identical and 
theoretically code for 33-kD protein of 302 amino acid (aa). It consists of a 76 aa 
acidic N-terminus, a 136 aa hydrophobic middle segment rich in serines, and a 90 
aa C-terminus with the conserved three zinc fingers (fig. 3). Additional features 
KLF1 ‘5 A G G  G T G  T G G 3’ 
KLF4 ‘5 A G G  G C G  T A G 3’ 
KLF5 ‘5 G G G  G C G  G G G 3’ 
KLF6 ‘5 T G G  G T G  G G G 3’ 
KLF7 ‘5 N G G  G N G  N G G 3’ 
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include a nuclear localization signal (NLS) KKRVHR (aa 215-220), a potential 
phosphorylation site by ERK kinases in the hydrophobic segment and an in vitro 
binding to the consensus sequence 5’ GGNGNGGGN 3’ (Matsumoto et al., 
1998). Moreover Matsumoto et al., showed by CAT assay that the transcriptional 
activation property lies within the amino-terminal region, and, by FISH analysis, 
that the hKlf7 gene maps to chromosome 2q33.3, a segment of conserved synteny 
with mouse chromosome 1, C2, where the mKlf7 gene is located.  
It has been identified also a Drosophila KLF7 orthologue. Indeed a database 
search with the conserved region of the mammalian KLF6/KLF7 group yielded 
the identification of the Drosophila gene Luna. Its DNA-binding domain bears 
97% similarity to the mammalian KLF7 and additionally, high levels of sequence 
homology were found in 47 aa of the acidic domain, the nuclear localization 
signal and the putative protein interaction/ ERK consensus sequence (De Graeve 
et al., 2003). 
 
 
 
 
 
 
Figure 3: Schematic view of the KLF7 protein 
Amino acids references at the points of transition are indicated with numbers. 
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1.4.1 The Krüppel-Like Factor 7 expression. 
 
Preliminary northern analysis on human newborn tissues showed the ubiquitous 
expression of hKLF7, indeed it was originally called UKLF, for ubiquitously 
expressed KLF (Matsumoto et al., 1998). Further analysis on mouse tissues 
showed that, during development, Klf7 expression is predominantly confined to 
the nervous system and that it can be divided into three distinct phases (Laub et 
al., 2001).  
In the embryonic phase Klf7 mRNA appears at about embryonic stage (E) 9,5 
both in the central nervous system (CNS) and in the peripheric nervous system 
(PNS), is maximal at about E11,5 and declines later. By E11,5 Klf7 is intensively 
expressed in the forebrain, midbrain, hindbrain, the neural tube, the trigeminal, 
superior cervical and dorsal root ganglia (DRG). It is remarkable the strong Klf7 
expression in the ventral midbrain (Mb) where the important contingents of 
dopaminergic neurons reside; as I will explain later, this developmental stage is 
crucial for dopaminergic neurons development. From E11,5 to E16,5 Klf7 
expression turn from to be predominant in the nervous system to be weak and 
diffusely distributed throughout the whole embryo (fig. 4a). 
Klf7 postnatal expression is accumulated most strongly in the cerebral cortex and 
hippocampus, nasal epithelium, trigeminal ganglion and rostral migratory stream 
(RMS) (fig. 4b). In the adult stage Klf7 is almost exclusively confined to the 
cerebellum and DRG, and with lower intensity is still expressed in the olfactory 
bulbs (OB), hippocampus and some brain-stem nuclei (fig. 4c). 
In summary, Klf7 is not expressed in the proliferative ventricular zone of spinal 
cord or brain, but only in the developing mantle zone and cortical plate, which 
contain differentiating postmitotic neuroblasts. 
In accordance with the mouse KLF7 expression, analysis of Luna by northern blot 
and in situ hybridization (ISH) showed that its expression in the Drosophila 
embryo peaks between stages 6 and 15 and is strictly confined to the nervous 
system of the fully developed embryo (De Graeve et al., 2003). 
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Figure 4: Temporal profile of Klf7 expression. 
Klf7 ISH analysis on sagittal sections, during embryonic development (a), at P2 (b) and at adult 
stage (c). Abbreviations: fb, forebrain; mb, midbrain; hb, hindbrain; nt, neural tube; drg, dorsal 
root ganglia; scg, superior cervical ganglia; tg, trigeminal ganglia; pc, plexus coeliacus; ne, nasal 
epithelium; cn, cerebral cortex; hc, hippocampus; ob, olfactory bulb; c, cerebellum; bn, brain stem 
nuclei (Laub et al., 2001). 
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1.4.2 The Krüppel-Like Factor 7 functional role. 
 
1.4.2.1 KLF7 molecular function. 
 
Using Tet-on/Tet-off inducible gene system Ramirez and coworkers showed that 
KLF7 overexpression in cultured fibroblasts, results in decreased DNA-
replication and, at the same time, increase in the expression of the cyclin 
dependent kinase (CDK) inhibitor p21waf/cip (Laub et al., 2001). Consistent with 
these findings, growth arrest and upregulation of p21waf/cip were also induced by 
overexpressing KLF7 through an adenoviral vector in the human neuroblastoma 
cell line NB-OK-1 (Laub et al., 2001). Further it has been demonstrated that 
KLF7 directly binds to and stimulates the activity of the proximal promoter of the 
CDK inhibitor p21waf/cip and p27kip1 genes (Smaldone et al., 2004; Laub et al., 
2005).  
These data suggest that KLF7 has an antiproliferative effect and may participate 
in neuroblast differentiation and cell cycle exit. 
 
 
1.4.2.2 KLF7 biological function. 
 
Most of KLFs are implicated in regulating important developmental programs, 
such as erythropoiesis, vasculogenesis and lymphopoiesis.  KLF7 plays a similar 
role in the developing nervous system. The functional data about KLF7 role 
during development derive mainly from the analysis of the Klf7-knockout (KO) 
mouse. Loss of KLF7 activity in mice leads to neonatal lethality, severely affects 
the development of the olfactory system and perturbs neurite outgrowth and 
branching throughout the nervous system (Laub et al., 2005).  
In the CNS of Klf7-KO mice, particularly evident is the olfactory bulbs (OB) 
hypoplasia, the dendritic impairment in the hippocampus and the axonal 
misprojections in the cortex (fig. 5).  
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Figure 5: Klf7-KO brain characterization 
a) Lack of fully formed OB in Klf7-KO brain (white arrow); b) hematoxylin and eosin staining 
showing impaired dendritic arborization in Klf7-KO hippocampus. In the lower panels is shown a 
Golgi-Cox staining on pyramidal neurons corresponding to the green shaded areas; c) Sections 
stained by anti-TAG-1 antibodies to visualize cortical efferent projections at two levels along the 
rostral-caudal axis; d) sections stained by anti-L1 antibodies to visualize cortical afferent 
projections at two levels along the rostral-caudal axis. The yellow arrow indicates fiber 
misprojection, whereas the white arrow highlights axon hyperfasciculation (Laub et al., 2005). 
 
To further investigate about the olfactory system deficit in Klf7-KO mice, it has 
been performed an RNA microarray analysis on wild type (wt) and Klf7-KO 
olfactory epithelium (OE) that revealed alterations of the expression levels of a 
number of genes involved in synaptic vesicle trafficking and neurotransmission, 
axon growth, regulation of cytoskeletal dynamics, and cell adhesion. Among the 
latter, the L1cam cell adhesion molecule and the OSN-specific Omp showed to be 
directly activated by KLF7 binding (Kajimura et al., 2006). Thus KLF7 role 
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during nervous system development seems to be directly involved in cell adhesion 
and neuronal morphogenesis processes. 
In the PNS Klf7 is coexpressed with TrkA in sensory and sympathetic neurons 
during development and binds specifically to an Ikaros core binding element that 
is crucial for in vivo TrkA enhancer function (Lei et al., 2001). Moreover in Klf7-
KO mice there is a significant reduction in nociceptive neurons that normally 
depends on TRKA for NGF neurotrophic support (Lei et al., 2005). These data 
indicate that KLF7 may directly regulate TrkA gene expression during PNS 
development. 
Subsequently it has been suggested that KLF7 may have a broad biological role, 
not only in the nervous  system. Indeed Loh et al. (2006) showed that KLF7 is a 
potential direct target of stemness master genes such as Oct4 and Nanog in ES 
cells (Boiani et Scholer, 2005). Moreover KLF7 was found to be potentially 
implicated in the ES cells self-renewal regulatory pathways (Ivanova et al. 2006). 
In addition, Klf7 overexpression leads to a remarkable inhibition of adipogenesis 
both in mouse 3T3-L1 preadipocytes cells and in human preadipocytes 
(Kanazawa et al. 2005, Kawamura et al. 2006). 
In Drosophila it has been shown that Luna ectopical overexpression in various 
tissues at different times during development, resulted in a variety of 
abnormalities, including inability to fly due to wing malformation or to react to 
mechanically exerted stimuli, as well as malformation of the eye. These 
phenotypic consequences of Luna misexpression suggest a role in cell 
differentiation and embryonic development, not unlike those mentioned for its 
mammalian counterpart (De Graeve et al., 2003). 
In summary Klf7 biological role is tightly linked to developmental processes. 
Experimental evidence has highlighted a clear role for KLF7 in the nervous 
system development, but still it is not known if KLF7 is involved in the 
development of specific populations of CNS neurons. Given its expression in the 
ventral Mb it is attractive to imagine a KLF7 involvement in dopaminergic neuron 
development. Moreover Klf7 expression in the RMS, legitimize the question 
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about the link between neural stem cells (NSC) and KLF7 function. It is useful to 
briefly describe these two neural populations.  
 
1.5 Neural stem cells. 
 
NSC are characterized by three cardinal features: (i) they are ‘self-renewing’, with 
the theoretically unlimited ability to produce progeny indistinguishable from 
themselves; (ii) they are proliferative, continuing to undergo mitosis (though 
perhaps with quite long cell cycles); and (iii) they are multipotent for the different 
neuroectodermal lineages of the CNS, including the multitude of different 
neuronal and glial subtypes (McKay R. 1997). 
 
1.5.1 NSC location in the embryonic and adult mammalian CNS. 
 
In the mammalian embryonic CNS, particularly in the ventral telencephalon 
during mid-neurogenesis and, to a lesser extent, in the dorsal telencephalon, 
neuroepithelial cells give rise to radial glia, which differentiate into basal 
progenitors that each form two postmitotic neurons. Both radial glia and 
neuroectodermal cells can directly generate neurons (Gotz and Huttner, 2005), 
and both neuroepithelial cells and radial glia can self-renew while producing basal 
progenitors, neurons or glia. These self-renewing cell types share a similar 
epithelial morphology, both express the intermediate filament Nestin and have an 
apically located mitotic spindle, and both can be distinguished by an array of  
molecular markers, including brain lipid-binding protein (BLBP), RC2, GLAST, 
and PAX6 (Gotz 2003; Rakic 2003).  
In the adult mammalian brain, neurogenesis constitutively occurs only in the OB 
and the dentate gyrus of the hippocampus. In the olfactory system, precursor cells 
reside in the anterior aspect of the subventricular zone (SVZ, sometimes also 
called the subependymal zone) in the walls of the lateral ventricles, migrate via 
‘chain migration’ through a structure surrounding the remnants of the olfactory 
ventricle (RMS) into the OB, and differentiate into granule or periglomerular 
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interneurons (Lois & Alvarez-Buylla 1993; Luskin 1993; Goldman 1995; Doetsch 
et al. 1999). In the dentate gyrus of the hippocampus, the precursor cell 
population is found in the subgranular zone (SGZ) of the dentate gyrus. Here, new 
hippocampal granule cell neurons are produced. These two brain regions are thus 
referred to as ‘neurogenic regions’ of the adult brain.  
 
1.5.2 An in vitro tool to study NSC: neurospheres. 
 
Neurospheres are floating structures than can be obtained by exposing dissociated 
embryonic or adult CNS tissue to growth factors (Reynolds et al., 1992; Reynolds 
and Weiss, 1992, 1996; Weiss et al., 1996). These heterogeneous spheroid 
structures contain NSC progenitors and differentiated cells embedded in a 
complex extracellular matrix (ECM) and organized threedimensionally with a 
core of differentiating glial fibrillary acidic protein (GFAP)+ and  β-tubulin III+ 
cells surrounded by Nestin+, epidermal growth factor receptor (EGFR)+ and β1 
integrin+ undifferentiated cells (Campos et al., 2004). Neurospheres are useful to 
evaluate NSC multipotentiality (through the characterization of cell phenotypes 
that arise from a differentiating sphere) and to analyze NSC self renewal using 
clonal secondary neurosphere assay that assume isolate true stem cells can 
generate new spheres. 
 
1.6 The dopaminergic system. 
 
The dopaminergic system is composed by groups of neurons producing the 
neurotransmitter dopamine (DA). DA is one of the catecholaminergic (CA) 
neurotransmitters of the vertebrate CNS, where it is synthesized in a common 
biosynthetic pathway as a precursor to noradrenaline and adrenaline. Tyrosine 
hydroxylase (TH) is the first and rate-limiting enzyme in this pathway that 
converts the essential amino acid tyrosine to L-dihydroxy-phenylalanine (L-
DOPA). LDOPA is then decarboxylated by the enzyme L-aromatic amino acid 
decarboxylase (AADC/DDC) to produce dopamine (fig. 6).  
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Figure 6: Dopamine biosynthesis pathway. 
The enzymes mediating each biochemical step are indicated on the arrows. 
 
Expression of Th has therefore been widely used as a molecular marker for CA-
synthesizing neurons. Much attention has been paid in recent years to the 
population of DA neurons in the mammalian brain given their pivotal role in the 
control and modulation of motor and endocrine functions, and affective and 
cognitive behaviours. The cell bodies of these neurons are found in stereotypic 
positions within the mammalian brain (Bjorklund and Dunnet, 2007), as listed 
below from caudal to rostral (fig. 7): 
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Figure 7:  Distribution of dopaminergic neurons in the adult rodent brain. 
The dopamine neurons in the mammalian brain are localized in nine distinctive cell groups, 
distributed from the ventral Mb to the OB, as illustrated schematically, in a sagittal view. Arrows 
illustrate the principal projections of the DA cell groups. 
 
1) DA neurons of the ventral midbrain are arranged in three distinct 
nuclei: the substantia nigra pars compacta (SNc), the ventral tegmental area 
(VTA); in the retrorubral field (RrF). Historically, these DA cell groups were 
designated A8 (RrF), A9 (SNc) and A10 (VTA). They represent a small 
contingent of CNS neurons, from a few thousands in the rodent to a few hundred 
thousands in human. Cells of the SNc are involved in the control of voluntary 
movements and postural reflexes, and their degeneration in the adult brain leads 
to Parkinson’s disease (PD), whereas cells of the VTA modulate rewarding and 
cognitive behaviours, and their dysfunction is involved in the pathogenesis of 
addictive disorders, depression, attention deficit hyperactivity disorder and 
schizophrenia. 
2) Another population of DA neurons is found in the diencephalon and 
comprises the A11–A15 groups consisting of approximately 1000 cells. The 
largest groups are the DA neurons of the posterior hypothalamus (A11) and of the 
zona incerta in the ventral thalamus (A13).  
3) Finally, a small DA cell population is found in the telencephalon, 
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comprising the A16 group of olfactory bulb periglomerular interneurons and the 
A17 group of retina amacrine interneurons. 
 
1.6.1 Development of dopaminergic neurons. 
The establishment of functional Mb-DA neurons from multipotent progenitors is 
orchestrated by cell-intrinsic factors and environmental cues and occurs through a 
complex multi-step process with a number of stages: early Mb patterning, 
induction of precursors, differentiation of postmitotic neurons, and functional 
maturation (Abeliovich and Hammond 2007; Ang 2006). Key regulators of this 
developmental time course are the activation of TFs and the action of secreted 
molecules. Their role and subsequent action in the various stages of rodent DA 
neuron development are summarized in figure 8. 
 
 
 
 
 
Figure 8: Diagram model of midbrain dopaminergic neuron development.  
The diagram summarizes the sequential stages and the molecules involved in rodent midbrain DA 
neuron embryonic development. The expression of TFs and secreted molecules involved in the 
induction, specification, differentiation and maturation of the Mb-DA phenotype are indicated, at 
various embryonic (E) ages. Arrows indicate possible interactions between these networks of 
molecules (Perrone-Capano et al., 2008). 
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1.6.1.1. Early midbrain patterning and induction of DA precursors. 
 
The specification of the permissive region for DA neuron generation is a 
fundamental event that initially occurs through the formation and positioning of 
molecular borders, such as the mid-hindbrain junction (MHJ, also known as 
isthmus). Together with the floor plate, an embryonic structure lining the ventral 
midline of the neural tube, the MHJ is a key signaling center in the developing 
Mb. Initially, expression of the two homeodomain TFs, Otx2 in the Mb and Gbx2 
in the hindbrain, are required for positioning the MHJ, which is a source of 
inductive molecules required for the specification of the Mb-DA neuronal field. 
Both Otx1 and Otx2 play a remarkable role in specification and regionalization of 
the forebrain and Mb (Simeone et al. 2002). Gbx2 regulates Mb and cerebellar 
development primarily through the secreted fibroblast growth factor-8 (FGF8). 
The latter, together with the morphogen Sonic hedgehog (SHH), derived from the 
floor plate of the ventral midline, cooperate in the induction of DA neurons early 
during gestation (before day E9.5 in mouse).  
 
1.6.1.2. Differentiation of postmitotic DA neurons. 
 
Recent studies indicate that Mb-DA neuroblasts, generated near the MHJ, are 
derived from the medial floor plate region (Kittappa et al. 2007). As these 
precursors exit from the cell cycle, they radially migrate from the ventricular 
surface to their final position in the ventral Mb. Birthdating studies using 3H-
thymidine incorporation show that DA progenitors exit the cell cycle and generate 
postmitotic immature Mb-DA neurons between E9.5 and E13.5 in rodents (Bayer 
et al. 1995). Immature Mb-DA neurons then further differentiate into mature DA 
neurons that express TH, in addition to the other markers mentioned above. The 
first TH+ cells and fibers have been detected close to the ventricular ependymal 
layer, suggesting that DA differentiation can occur in early radially migrating 
postmitotic Mb-DA precursors (di Porzio et al. 1990). Several key TFs, such as 
Engrailed (En) 1 and 2, Nurr1, Pitx3 and Lmx1b are involved in the development 
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of postmitotic Mb-DA neurons (fig. 7). However, none of these TFs appears by 
itself sufficient to specify all aspects of mature Mb-DA phenotype, suggesting 
that they must act in a combinatorial manner.  
 
1.6.1.3. Maturation and survival of the dopaminergic phenotype. 
 
Following the early commitment of DA neuroblasts, the activation of genes 
involved in DA neurotransmission takes place in a precise temporal sequence 
during embryonic development under the control of various environmental cues. 
By monitoring the expression of a number of “dopaminergic” genes and their 
function during embryonic development of the Mb, it has been shown that DA 
synthesis, storage and high-affinity uptake develop asynchronously (Perrone-
Capano and di Porzio 1996, 2000). Following Th gene expression, the gene 
codifying for Vmat-2 is readily expressed. These events take place several days 
before the establishment of nigrostriatal connections (which in rodents occurs at 
E15–16). They suggest that VMAT-2 could play a protective role before the 
establishment of functional DA neurotransmission, since its activity is necessary 
to accumulate DA into presynaptic vesicles and thus clear it from the cytoplasm. 
Thus, VMAT-2 limits DA oxidation (since dense core vesicle pH is acidic) and its 
neurotoxic effects. 
Interactions of presynaptic Mb-DA neurons with striatal target neurons play an 
important role, at least in vitro, in promoting key aspects of DA 
neurotransmission, namely DA synthesis and uptake, mediated by TH and the 
dopamine transporter (DAT), respectively (Prochiantz et al. 1979; di Porzio et al. 
1980; Perrone-Capano and di Porzio 1996). 
Interestingly, recent data support the hypothesis that correct target recognition 
may improve maintenance and survival of DA neurons. It has been proposed that 
ephrin signaling (involved in axonal guidance) can regulate the correct targeting 
of nigrostriatal neurons (Yue et al. 1999). Indeed application of ephrin-B2 
(expressed in vivo by the developing striatum) to Mb cultures results in Nurr1 
upregulation (Calò et al. 2005). Other guidance cues can contribute to regulate 
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correct Mb-DA projections, such as netrin-1 and slit-2, which act in concert to 
regulate and direct Mb-DA neurites outgrowth (Smidt and Burbach 2007). 
 
1.7 Thesis project aim. 
 
During my thesis work I have studied the role of KLF7 both in cellular 
differentiation and in neuronal morphogenesis. My principal aims were: 
1) To understand KLF7 involvement in specific differentiation 
processes like neurogenesis, cardiogenesis, adipogenesis and osteogenesis. 
2) To analyse KLF7 role during mouse CNS embryogenesis. 
In my experimental plan I have used both in vitro and in vivo approaches to 
identify KLF7 biological functions.  
In the in vitro approach I have performed RNA interference (RNAi) experiments 
in order to analyse the effect of KLF7 depletion in the neuronal cell line PC12, 
and in embryonic stem (ES) cells differentiation processes. To further understand 
Klf7 functions in neuronal differentiation, I have compared self-renewal and 
neuronal differentiation ability of wt and Klf7-KO derived neurospheres. 
Moreover I have analysed the adipogenic and osteogenic potential of mouse 
embryonic fibroblasts (MEF) derived from Klf7-KO mice. 
In the in vivo approach I have initially analysed Klf7 expression during wt mouse 
brain ontogenesis, thus I have performed a transcriptional analysis of the Klf7-KO 
mouse brain. This analysis suggested that Klf7-KO mice share a dopaminergic 
deficit in the ventral Mb as well as in the OB, therefore I have further confirmed 
the Klf7 potential involvement in dopaminergic development, by 
immunohistochemical experiments. 
Altogether my thesis experiments aim to shed light on KLF7 functions during 
developmental processes. Even if it is known that KLF7 is indispensable for the 
proper development of the mouse embryo, my effort was aimed at clarifying some 
of the biological mechanisms involved. 
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2 MATERIALS AND METHODS 
 
 
2.1 Cell cultures. 
 
2.1.1 PC12 cells. 
 
PC12 cells were grown in RPMI medium (Invitrogen, Milan, Italy), with 10% 
horse serum (HS, Invitrogen), 5% fetal bovine serum (FBS, Invitrogen) and 
100U/ml penicillin/streptomycin (Invitrogen). To induce neuronal differentiation 
cells were previously starved for 24 hr and then NGF (Alexis biochemicals, San 
Diego, CA, USA) 100 ng/ml wad added to the medium. Neurites formation was 
analysed 7 days after differentiation induction. 
 
2.1.2 ES cells. 
 
Undifferentiated E14/Tg2a ES cells were grown without feeders onto 0.1% 
gelatin-coated tissue dishes, in DMEM (Invitrogen) supplemented with 15% FBS 
(Hyclone, Logan, UT, USA), 0.1 mM β-mercaptoethanol (Sigma-Aldrich, Milan, 
Italy), 1 mM sodium pyruvate (Invitrogen), 1X non essential aminoacids 
(Invitrogen), 2 mM glutamine (Invitrogen), 100 U/ml penicillin/streptomycin 
(Invitrogen) and 103 U/ml leukemia inhibitory factor (LIF) (Chemicon 
International, Temecula, CA, USA). ES cells were routinely passaged every 2 
days, and the medium was changed on alternated days.  
 
2.1.2.1 ES cells neuronal differentiation. 
 
3 x 103 cells/cm2 ES cells were plated on 0,1% gelatin coated tissue culture in 
differentiation medium: Knockout Dulbecco’s minimal essential medium 
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supplemented with 15% Knockout Serum Replacement (both from Invitrogen), 
0,1 mM β-mercaptoethanol, 2 mM glutamine, 100 U/mL penicillin/streptomycin. 
Neurites outgrowth was analysed 8 days after neuronal induction (Kawasaki et al., 
2000, Ying et al., 2003, Fico et al., 2008). 
 
2.1.2.2  ES cells cardiogenic differentiation. 
 
20 µl drops of ES cells (400 cells/drop) in differentiation medium: [(DMEM 
(Invitrogen) supplemented with 15% FBS (Hyclone), 0.1 mM β-mercaptoethanol 
(Sigma-Aldrich), 1 mM sodium pyruvate (Invitrogen), 1X non essential 
aminoacids (Invitrogen), 2 mM glutamine (Invitrogen), 100U/ml 
penicillin/streptomycin (Invitrogen)] were placed on the lid of tissue culture 
dishes filled with phosphate buffered saline (PBS, Euroclone, Milan, Italy), and 
cultivated in hanging drops for 2 days. Two-day-old embryoid bodies (EBs) were 
then collected in differentiation medium and transferred into 100-mm 
bacteriological Petri dishes. After further 3 days of culture, 5 day-old EBs were 
plated in the same medium onto 0,1% gelatin-coated tissue culture plates. 
Cardiomyocitic formation was assayed at 8 days in culture (Maltsev et al., 1993). 
 
2.1.3 Mouse embryonic fibroblasts (MEF). 
 
2.1.3.1 MEF preparation. 
E14,5 embryos were took in sterile conditions and placed in PBS. The head and 
viscera were removed and decapitated embryos were washed in fresh PBS, trying 
to get rid of as many red blood cells as possible. The decapitated embryos were 
placed in a dish containing Trypsin/EDTA (Invitrogen), and using curved Iris 
scissors the tissue were quickly finely minced until it can be taken up in a 10ml 
pipette. More Trypsin/EDTA was added to the dish and again pipetted up and 
down with a 5ml pipette. Then, the dishes were placed back in the incubator for 
10 more minutes. All the contents of the dish were put in a 50ml conical tube. The 
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pieces of cellular debris were spinned down, and the supernatant was put into a 
fresh tube for a new wash with MEF medium (DMEM, 10% FBS, 100U/ml 
penicillin/streptomycin). Thus the suspension was spinned down again and the 
pellet resuspended in MEF medium and placed in a T-150 flask. Cells were let 
grow overnight in the incubator. After this time, the medium was changed to 
remove any cellular debris and the flask placed back in the incubator for another 
24 hours and then passaged. In order to maintain the primary cells characteristics, 
in all MEF experiments were used cells passaged no more than six times.  
2.1.3.2 MEF adipogenic differentiation. 
 
MEF were allowed to grow to 90-95% confluence and then cultured for two 
weeks in α-MEM (Invitrogen) supplemented with 10% FBS, 10% HS, 2 mM L-
glutamine, 100 U/ml penicillin/streptomycin, 10-6 M dexamethasone (Sigma-
Aldrich), 5 µg/ml insulin (Sigma-Aldrich), 0.5 µM 3-Isobutyl- 1-methylxanthine 
(IBMX) (Sigma-Aldrich) and 50 µM indomethacin (Sigma-Aldrich) changing 
medium every 3-4 days (Digirolamo et al., 1999).  
 
2.1.3.3 Oil red-O staining. 
 
Cells were washed with PBS and fixed in 10% formaldehyde for 10 minutes. 
After rinsing with distilled water, they were stained with 0,5% oil red-O working 
solution prepared by vigorously mixing 3 parts of a stock solution (0,5% Oil red-
O in isopropanol) (Sigma-Aldrich) with 2 parts of water for 5 minutes and 
filtering through a 0,4 µm filter. Excess staining was removed by washing twice 
with PBS. Cells were then counterstained with hematoxylin (Bio-Optica) for 3 
minutes and then washed with distilled water (Digirolamo et al., 1999). Dye was 
extracted by isopropanol incubation for 15 minutes at room temperature (RT). 
Quantitative assessment was obtained by absorbance of a five-fold dilution of the 
extracted dye at 540 nm.  
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2.1.3.4 MEF osteogenic differentiation. 
 
MEF were allowed to grow to 70-90% confluence and then cultured for 3 weeks 
in α-MEM supplemented with 10% FBS, 2 mM L-glutamine, 10 U/ml penicillin -
10 µg/ml streptomycin,10-8 M dexamethasone, 0,05 mM ascorbic acid 2-
phosphate (Sigma-Aldrich) and 10 mM β-glicerophosphate (Sigma-Aldrich), 
changing medium every 3-4 days (Phinney et al., 1999).  
 
2.1.3.5 Alizarin red S staining. 
 
Cells were washed with PBS and fixed in 10% formaldehyde for 1 hour; after 
rinsing with distilled water, they were incubated with 2% alizarin red S (Sigma-
Aldrich) pH 4,1 with gentle shaking for 10 minutes. Excess staining was removed 
by washing twice with PBS (Digirolamo et al., 1999). Dye was extracted by 
overnight incubation with 4M guanidine-HCl (Sigma-Aldrich) at RT. Absorbance 
at 490 nm of a five-fold dilution of the resulting supernatant was used for 
quantitative mineralization determination. 
 
2.1.4 Neurospheres. 
 
Under a stereoscope in sterile conditions P0 brains were removed and overlying 
meninges and blood vessels were discarded. The striatal germinal zone (GZ) was 
dissected according to the coordinates reported in rodent brain atlas (Sherwood 
and Timiras, 1970; Kruger et al., 1995). The tissue was transferred to 500 µl of 
DMEM/F12 (Invitrogen) medium and mechanically dissociated into a cell 
suspension with a fire-polished Pasteur pipette. Thus the cells were counted and 
cultured in suspension 2,5x105/ml with neurospheres medium [DMEM/F12, B27 
(Invitrogen), N2 (Invitrogen), bFGF and EGF (both 20ng/ml, Sigma-Aldrich)] in 
25cm2 flasks with no substrate pretreatment. Primary neurospheres were formed 
after 4-5 days in vitro, thus every week were softly spinned down (75g), 
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mechanically dissociated and the medium was changed. In order to maintain the 
primary neurospheres characteristics all experiments were performed with cells 
passaged no more than 10 times.  
 
2.1.4.1 Neurospheres neural differentiation. 
 
To evaluate neural differentiave potential, neurospheres were dissociated and 
plated 5x104 cells/cm2 on poli-D-lysine (15µg/ml, Sigma-Aldrich) precoated 
plates in neurospheres medium. After 6 days in culture, cells were kept for 
additional 3 days without bFGF and EGF, thus neuronal, astroglial and 
oligodendroglial differentiation were assessed by immunocytochemical analysis. 
 
2.1.4.2 Neurospheres assay. 
 
To determine the self-renewal skill of secondary neurospheres, primary 
neurospheres were mechanically dissociated into single cells with a fire polished 
Pasteur pipette, and an aliquot was counted and cultured 500 cells/200 µl/well in 
96-well plates ultra-low attachment (Corning, Milan Italy) (Reynolds and Weiss, 
1996). Thus each week, secondary neurospheres formed in each well were 
counted and passaged in a new single well. 12 wells for both wt and Klf7-KO 
neurospheres were assayed along 4 weeks. 
2.2 Cell transfections. 
All cell lines were transfected by lipofection using Lipofectamine 2000 
transfection reagent (Invitrogen). All tranfections were performed in triplicates 
samples. Transfected cells were selected with puromycin (Sigma-Aldrich) 2µg/ml 
48 hr after transfection. For each experimental condition three pools of resistant 
clones were generated and were kept separated in all real time RT-PCR and 
western blot experiments.  
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2.2.1 RNAi. 
 
To silence Klf7, Oct4 or Nanog genes expression I used short hairpin RNA 
(shRNA) expressing vectors contained in the Expression ArrestTM mouse shRNA 
library (Open Biosystems, Huntsville, AL, USA). In all RNAi experiments a short 
hairpin non silencing (shNS) vector was used as control.  
2.3 Animal and dissections. 
Timed pregnant wt, Klf7-heterozygous (het) mice and postnatal day (P)0 or P10 
pups (Charles River Breeding Laboratories, Milan, Italy) were sacrificed in 
accordance with Society for Neuroscience guidelines and Italian law. The 
embryonic age (E) was determined by considering the day of insemination (as 
confirmed by vaginal plug) as day E0. Embryos from day 11,5 to E17,5 of 
gestation were quickly removed and placed in PBS, without calcium and 
magnesium, and supplemented with 33 mM glucose. All the tissues both from 
embryos and pups, were dissected according to the coordinates reported in rodent 
brain atlas (Sherwood and Timiras, 1970; Kruger et al., 1995) and processed for 
RNA extraction or cell cultures. All embryos and pups tissues deriving from Klf7-
het pregnant mice, were processed separately and a tail sample was processed for 
genotyping. 
 
2.3.1 Mice genotyping. 
 
Tail samples were put in 500 µl of lysis buffer [100 mM Tris-HCl pH8,5, 5 mM 
EDTA, 0,2% SDS, 200 mM NaCl, 100 mg/ml proteinase K (Roche, Milan, Italy)] 
overnight at 55°C. Thus DNA was extracted adding 500 µl of chloroform/isoamyl 
alchol (24:1) shaking for a few seconds and centrifuging at 13000 g for 15 
minutes. The upper aqueous phase was collected and the DNA precipitated adding 
1 ml of EtOH and centrifuging at 7000 g for two minutes. Thus the DNA pellet 
was decanted and washed with 70% EtOH. Finally the DNA was dried and 
resuspended in 300 µl of distilled water. The genotype was identified by PCR 
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(Laub et al., 2005) with two pair of primers that amplify, the first exon of Klf7 wt 
gene and the PGK-neo cassette that replaces Klf7 first exon in the mutant mice 
(table 1).  
 
2.3.1.1 PCR analysis. 
2 µl of DNA were amplified in a 25 µl of reaction mixture containing AmpliTaq 
Gold DNA polymerase buffer (Applied Biosystems, Milan, Italy), 0,2 mM dNTPs 
(Finnzymes OY, Espoo, Finland), 0,4 µM each primer, 1 U AmpliTaq Gold 
DNApolymerase (Applied Biosystems). The termal profile of the amplification 
consisted of a first denaturing step of 5 minutes at 95 °C, 35 cycles of 30 seconds 
at 95 °C, 40 seconds at 63 °C and 1 minute at 72°C, followed by a final extension 
of 10 minutes at 72°C.  The wt (250 bp) or mutant (420 bp) amplified products 
were identified after gel electrophoresis in 1,5% agarose gel. 
 
 
Target Sequence (5’-3’) Amplicon length (bp) 
Bdnf fw ACAATGTGACTCCACTGCCG 
Bdnf rv CACTCTTCTCACCTGGTGGAACT 70 
Blbp fw CCAGCTGGGAGAAGAGTTTGA 
Blbp rv CATCCAACCGAACCACAGACT 70 
Cacna1a fw TGCTGAACCTTGTTCTGGGTG 
Cacna1a rv TCTCCGGTTCTCCACACGTT 70 
Cacna1b fw  ATGGACTTCGTGGTGGTCCTC 
Cacna1b fw CTCAGTGTGCGCAGGTCAAA 70 
Dat fw TCTGGGTATCGACAGTGCCA 
Dat rv GCAGCTGGAACTCATCGACAA 
70 
Dbh fw GACCGGCTACTGCACAGACAA 
Dbh rv GAGAGGCAAAGATGTGGATTCC 
70 
Dlx2 fw GTCAACAACGAGCCGGACA 
Dlx2 rv ACTTTCTTTGGCTTCCCGTTC 
70 
Dlx5 fw CTACAACCGCGTCCCGAG 
Dlx5 rv TCACCATCCTCACCTCTGGC 
70 
Drd1 fw  CTGGCACAAGGCAAAACCTAC 
Drd1 rv  TGTCATCCTCGGCATCTTCC 
70 
Drd2 fw GCACAGCAAGCATCTTGAACC 
Drd2 rv  CAACATAGGCATGGCCACAG 
70 
Drd3 fw  TCCTCACTAGACAGAACAGCC 
Drd3 rv  CCGCAGACAGGAAGACTGCT 
70 
Drd4 fw AAGGGAGCGCAAGGCAAT 
Drd4 rv AGAAAGGCGTCCAACACACC 
70 
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Target Sequence (5’-3’) Amplicon length (bp) 
Drd5 fw GAGACACCCTGGGAGGAAGG 
Drd5 rv GTTCGGTTCAGGCTGGAGTC 
70 
Eaat1 fw  CCTTCGTTCTGCTCACGGTC 
Eaat1 rv  TTTATACGGTCGGAGGGCAA 
70 
En1 fw CGCCTGGGTCTACTGCACA 
En1 rv  TCTTCTTTAGCTTCCTGGTGCG 
70 
En2 fw  GACCGGCCTTCTTCAGGTC 
En2 rv GGCCGCTTGTCCTCTTTGT 
70 
Foxa1 fw GAAGGGCATGAGAGCAACGA 
Foxa1 rv  ACAGGGACAGAGGAGTAGGCC 
70 
Foxa2 fw ACGAGCCATCCGACTGGAG 
Foxa2 rv  GGCGTTCATGTTGCTCACG 
70 
Gabat fw CAATGTGGCCCGTGTGG 
Gabat rv TGAACTGAGGGTACTGGGCCT 
70 
Gad1 fw TGCCAAACAAAAGGGCTATGT 
Gad1 rv CGAATGCTCCGTAAACAGTCG 
70 
Gad2 fw AGGGTTACTGATGTCCCGGAA 
Gad2 rv TCCATGTCACAGAGTTGGC 
70 
Gapdh fw GTATGACTCCACTCACGGCAAA 
Gapdh rv TTCCCATTCTCGGCCTTG 
70 
Gat1 fw GCTGATGCTGGGCATTGAC 
Gat1 rv GGTACTCGTCCACCAGGGC 
70 
Gat2 fw TCTTCATCATGCTCCTGTTTCTAGG 
Gat2 rv GGAAGCGGTCACCAGGC 
70 
Gat3 fw GTGACCTCCGAGAATGCCA 
Gat3 rv CCATCCGAGAGCTTCAGGACT 
70 
Gat4 fw CACCTTGTTCTTCATGATGCTCA 
Gat4 rv TCACAAGACTCTCCACGCACAC 
70 
Gdnf fw AGGTCCGGATGGGTCTCCT 
Gdnf rv TCTCCGTAGACCCCCAGTTG 
70 
Hprt fw TGCCCTTGACTATAATGAGTACTTCAG 
Hprt rv TTGGCTTTTCCAGTTTCACTAATG 
70 
Klf7 fw CACTTAAAGGCCCACCAGAGG 
Klf7 rv CACTCGCATCCTTCCCATG 
70 
Klf7 exon 1 fw TTTCCTGGCAGTCATCTGCAC 
Klf7 exon 1 rv GGGTCTGTTTGTTTGTCAGTCTGTC 
250 
Lmx1a fw AACCAGCGAGCCAAGATGAA 
Lmx1a rv TGGGTGTTCTGTTGGTCCTGT 
70 
Lmx1b fw ACACAGCAGCGAAGAGCTTTC 
Lmx1b fw GTCTCTCGGACCTTCCGACA 
70 
Map2 fw AACGGGATCAACGGAGAGCT 
Map2 rv TGTGACTACTTGAACTATCCTTGCAGAT 
70 
Mash1 fw GGGAATGGACTTTGGAAGCA 
Mash1 rv ATTTGACGTCGTTGGCGAG 
70 
Mecp2 fw  GGATTCCATGGTAGCTGGGA 
Mecp2 rv TGAGGCCCTGGAGATCCTG 
70 
Msx1 fw CTCCCCGCCCCCAGCCAGAC 
Msx1 rv GGGCTTGCGGTTGGTCTTGT 
70 
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Target Sequence (5’-3’) Amplicon length (bp) 
Nanog fw TGCTACTGAGATGCTCTGCACAG 
Nanog rv TGCCTTGAAGAGGCAGGTCT 
70 
Neurod fw TGAGATCGTCACTATTCAGAACCTTT 
Neurod rv CGCTCTCGCTGTATGATTTGG 
70 
Ngn1 fw CCAGTAGTCCCTCGGCTTCA 
Ngn1 rv CAGGCCAGGAAAGGAGAAAAG 
70 
Ngn2 fw ATCTGGAGCCGCGTAGGAT 
Ngn2 rv CATCAGTACCTCCTCTTCCTCCTTC 
70 
Nurr1 fw GTGCCTAGCTGTTGGGATGG 
Nurr1 rv GTAAACGACCTCTCCGGCC 
70 
Oct4 fw AACCAACTCCCGAGGAGTCC 
Oct4 rv CAGCAGCTTGGCAAACTGTTC 
70 
Otx2 fw TAACGTCCAATGCGGCTGTA 
Otx2 rv GGAGTGGACAGGGTCAGGGT 
70 
p21 fw CCACAGCGATATCCAGACATTC 
p21 rv GCGGAACAGGTCGGACAT 
70 
PGK-neo fw CCCCTTCGCGCCACCTTCTACTCCTC 
PGK-neo rv TGAGCCCAGAAAGCGAAGGAGCAAAG 
420 
Phoxa2 fw AAGATCGACCTCACTGAGGCTC 
Phoxa2 rv TCCTGTTTGCGGAACTTGG 
70 
Pitx3 fw GACGCAGGCACTCCACACC 
Pitx3 rv TTCTCCGAGTCACTGTGCTC 
70 
Ret fw TGAACCTACCCAGGGCCTACT 
Ret rv GACTTTCCCGATCTGGGCAT 
70 
RhoA fw AGAAGGACCTTCGGAATGACG 
RhoA rv AGGTTTTACCGGCTCCTGCT 
70 
Sert fw GGAACGAAGACGTGTCCGAG 
Sert rv TGCCTCCGCATATGTGATGA 
70 
Th fw CTCACCTATGCACTCACCCGA 
Th rv GGTCAGCCAACATGGGTACG 
70 
Tph1 fw ACAACATCCCGCAACTGGAG 
Tph1 rv CACAGGACGGATGGAAAACC 
70 
Tph2 fw GACCACCATTGTGACCCTGAA 
Tph2 rv ACGGCACATCCTCGAGATCT 
70 
TrkA fw TCGTGGCTGTCAAGGCACT 
TrkA rv CAGCTCGGCCTCACGCT 
70 
Uncx4.1 fw TCCCGAGTTCAGGTCTGGTT 
Uncx4.1 rv GGGCCCTTTTTGGTGTTCTC 
70 
Vgat fw AGCGGGCTGGAACGTGA 
Vgat rv CGTGGAGGATGGCGTAGG 
70 
Vmat2 fw TTGCTCATCTGTGGCTGGG 
Vmat2 rv  TGGCGTTACCCCTCTCTTCAT 
70 
 
Table 1: List of primers used for PCR and real time RT-PCR analyses. 
The table shows the forward (fw) and reverse (rv) primers sequence with length of amplified 
fragments used in PCR and real time RT-PCR experiments. 
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2.4 RNA isolation and real-time RT-PCR analysis. 
 
Total RNA was extracted from cell cultures or tissue samples using the Tri-
Reagent isolation system (Sigma-Aldrich) according to the manufacturer’s 
instructions (Chomczynski and Sacchi, 1987). Tissue samples were previously 
triturated using a plastic coated grinder. The analyses were always carried in 
triplicate obtained from different pools of samples for each experimental 
condition and were processed separately. The yield and the integrity of RNA were 
determined by spectrophotometrical measurement of A260 and agarose gel 
electrophoresis, respectively. RNA was treated with DNA free kit (Ambion Inc., 
Milan, Italy) to eliminate possible DNA contaminations. Two µg of RNA were 
reverse transcribed using random hexanucleotides as primers (New England 
Biolabs Inc., Milan, Italy, 6 µM) and 200 U of moloney-murine leukemia virus 
reverse transcriptase (Ambion). Real time RT-PCR was carried out using the 
7900HT Fast Real-Time PCR System (Applied Biosystems). 1/50 of the reverse 
transcribed cDNA was amplified in a 25 µl reaction mixture containing 1X SYBR 
Green PCR Master Mix (Applied Biosystems), and 0,4 µM each primer. The 
termal profile consisted of 2 minutes at 50 °C, 10 minutes at 95 °C, followed by 
40 cycles of 15 seconds at 95 °C and 1 minute at 60 °C. Gene expression was 
normalized with Glyceraldehyde-3-phosphate dehydrogenase (Gapdh) expression 
level in PC12 and ES cells experiments and with Hypoxanthine 
phosphoribosyltransferase (Hprt) [which is constantly expressed during CNS 
development (Steel et Buckley 1993)] in brain tissues analyses. All primers used 
for the real time RT-PCR experiments were designed with Primer Express 3.0 
software (Applied Biosystems) and are listed in table 1. 
 
2.5 Western blot analysis. 
 
For western blots analyses, cultures samples were lysed in a buffer 150 mM NaCl, 
10 mM Tris-HCl pH8, 0,4 mM EDTA, 1% Triton X-100, containing a cocktail of 
protease inhibitors (Roche, Milan, Italy). Protein content of each sample was 
determined by the Bio-Rad assay kit (Bio-Rad laboratories S.r.l., Milan, Italy). 50 
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µg/lane of proteins were separated on 12% SDS-polyacrylamide gel. Proteins 
were transferred to PVDF filters (Amersham biosciences, Milan, Italy) in transfer 
buffer (25mM Trizma, 193 mM glycine, 20% methanol). Filters were soaked for 
30 minutes in transfer buffer and were blot for two hours in blocking buffer 
(10mM Tris-HCl pH 8, 150 mM NaCl, 5% non fat dry milk). Membranes were 
probed for two hours at RT with anti-KLF7 (Abnova, Taipei, Taiwan, 1:5000), 
anti-BLBP (1:1000 custom made) or anti-β-ACTIN (1:5000 Santacruz 
Biotechnology Inc., Santacruz, CA, USA) antibodies in blocking buffer. After 
washing (four times for 5 minutes each) with TTBS (Tris-HCl 10 mM pH 8,0; 
NaCl 200 mM, Tween-20 0,1%) and once with TBS (Tris-HCl 10 mM pH 8,0; 
NaCl 200 mM), immunoblots were incubated with horse radish peroxidase 
conjugated anti-mouse IgG antibodies (1:10000, Amersham Biosciences) in 
blocking buffer for one hour at RT and washed as above. The reaction was 
detected with ECL plus procedure (Amersham Biosciences).  
 
2.6 Immunocytochemical analysis. 
 
Cell cultures were fixed for 30 minutes at RT in 4% paraformaldehyde in PBS, 
permeabilized for 15 minutes at RT in PBS containing 0,1% Triton X-100 and 
10% normal goat serum (NGS), and incubated for 2 hours at RT in PBS 
containing 10% NGS and primary antibody [anti-βTUBB3 1:1000 (Promega, 
Madison, WI), anti-GFAP 1:400 (Sigma-Aldrich), anti-NG2 1:400 (Chemicon), 
anti-BLBP 1:500, anti-Ki67 1:300 (BD Pharmigen), anti-PhosphoH3 1:500 (Cell 
Signaling Technology, Inc., Danvers, MA, USA), anti-Nestin 1:40 
(Developmental Studies Hybridoma Bank, Iowa City, IA, USA)]. The antigens 
were revealed with incubation for one hour at RT in PBS containing 10% NGS 
and anti-mouse or anti-rabbit secondary fluorescine or rhodamine conjugated 
antibodies (1:400, Chemicon). Nuclei were marked with the nuclear dye DAPI 
(Roche) and the slides were mounted with Vectashield (Vector Laboratories, 
Burlingame, CA, USA). Cells counting was performed on five fields from three 
replicates for each condition and normalized with DAPI positive cells. 
CHAPTER 2 – MATERIALS AND METHODS                                                  36 
 
2.7 Immunohistochemical analysis. 
 
P0 brains were fixed overnight at 4°C with 4% paraformaldehyde, buffered in 
30% sucrose until they sunk, to cryopreserve the tissue, and included in OCT. 
Frozen brains were cut in 15µm thick sections with a cryostat and processed for 
immunostaining. Thus frozen sections were permeabilized for 1 hour at RT in 
PBS containing 0,1% Triton X-100 and 10% normal NGS, and incubated for 2 
hours at RT in PBS containing 10% NGS and anti-TH antibody (1:200, 
Chemicon). The immunoreactive signal was revealed according to standard 
avidin-biotin immunocytochemistry procedures (Vectastain Elite), using a 
peroxidase substrate kit (DiAaminoBenzidine). 
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3 RESULTS 
 
3.1 Expression profile of Klf7 in proliferating and differentiated 
PC12 and ES cells. 
 
In order to test KLF7 relevance in cell differentiation pathways, I have first 
analyzed in two different cellular systems, its transcriptional modulation 
following differentiation. First I used the rat pheocromocytoma cell line PC12. 
PC12 cells are useful to study KLF7 functions, since KLF7 activates the 
transcription of the nerve growth factor (NGF) high affinity receptor TrkA (Lei et 
al., 2005), that in turn mediates PC12 neuronal differentiation following NGF 
administration. The other cellular system that I have used is the totipotent mouse 
ES cell line E14 tg2a. The use of ES cells is useful to comprehend the KLF7 
potential functions in the development of both ectodermal and mesodermal 
embryonic cell lineages, since they can be differentiated into neurons or 
cardiomyocytes.  
I have induced PC12 cells neuronal differentiation with NGF, then collected cells 
after 7 days in vitro and performed real time RT-PCR analysis on proliferating 
and differentiated cDNA samples. This experiment showed a significant increase 
in Klf7 transcripts. At the same time I have found a similar increase of p21wf/cip 
transcript, as expected since p21wf/cip is one of the few known KLF7 effectors 
(Laub et al., 2001)(fig. 1). 
ES cells were induced to differentiate into neurons by serum withdrawal, or, 
alternatively, into cardiomyocytes following EBs formation. In accordance with 
PC12 experiments, both neuron and cardiomyocyte differentiated cells shared a 
significant increase in Klf7 transcript and p21wf/cip transcript levels in 
differentiated samples (fig. 9).  
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Figure 9: Klf7 and p21 transcriptional changes in ES and PC12 cells following 
differentiation. 
The diagram shows the relative quantization (mean ± SE) of the Klf7 and p21 transcripts amplified 
product compared to that of the glyceraldehyde-3-phosphate dehydrogenase (Gapdh, internal 
standard). Data are expressed as ratio Klf7/Gapdh and p21/Gapdh. Asterisks represent p<0.05 
when compared to the indicated control cultures (ANOVA, Scheffè F-test).  
 
3.2 Klf7 gene silencing in PC12 cells. 
In order to investigate KLF7 function in cellular differentiation, I have performed 
experiments to silence Klf7 expression by RNAi. To this aim, I have used a short 
hairpin RNA (shRNA) expressing vector contained in a shRNA library. The 
shKlf7 construct was designed to specifically silence mouse Klf7 mRNA. In all 
RNAi experiments control samples were treated with a non- silencing RNA 
(shNS) expressing vector. 
In order to understand the role of Klf7 in neuronal differentiation, I have 
modulated its expression in PC12 cells by stable transfection of the shKlf7 or 
shNS vectors. Thus following puromycin selection I have obtained three pools of 
transfected clones for each construct. The different pools were kept separated in 
all the subsequent experiments. Samples of proliferating shNS-PC12 and shKlf7-
PC12 cells have been assayed by real time RT-PCR for Klf7 mRNA levels, 
showing no differences when compared to controls, consistently with the Open 
Biosystems shRNA library properties, designed to silence gene function at the 
protein level. Therefore KLF7 protein level has been assayed by western blots in 
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shNS-PC12 and shKlf7-PC12 cells. The result has shown a significant decrease of 
anti-KLF7 immunoreactive signal in shKlf7-PC12 samples compared to control 
shNS-PC12 clones (fig. 10). In these clones I have found a dramatic decrease of 
Klf7 transcripts (fig. 10), associated to a significant reduction of KLF7 protein, as 
showed for PC12 cells transiently transfected. Moreover real time RT-PCR 
analysis has shown that in shKlf7-PC12 stable clones, Map2 mRNA decreased 
synergistically with Klf7 mRNA (fig. 10). Finally to investigate whether KLF7 
protein depletion in PC12 cells could lead to a transcriptional change in genes 
involved in PC12 neuronal differentiation, I have analysed the mRNA levels of 
the NGF receptor TrkA in shKlf7-PC12 stable clones and found a significant 
reduction of its transcripts (fig. 10).  
 
Figure 10: Transcriptional analysis following Klf7 stable silencing in PC12 cells. 
The diagrams shows the relative quantization (mean ± SE) of the Klf7, Map2 and TrkA transcripts 
amplified product compared to that of the glyceraldehyde-3-phosphate dehydrogenase (Gapdh, 
internal standard). Data are expressed as ratio Klf7/Gapdh, Map2/Gapdh or TrkA/Gapdh. Analyses 
were performed in PC12 cells transiently transfected with shNS or shKlf7 vectors as indicated. 
Asterisks represent p ≤ 0.01 when compared to the indicated control cultures (ANOVA, Scheffè F-
test). The lower panel shows the western blot analysis of the KLF7 protein compared to that of β-
ACTIN (internal standard). 
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3.3. Klf7 gene silencing in ES cells. 
 
Using the same experimental paradigm used with PC12 cells, I have generated ES 
cells stably transfected with shNS or shKlf7 vectors. Also in shKlf7-ES stable 
clones there was a strong decrease of KLF7 protein level (fig. 11a).   
Thus to assess whether a KLF7 protein decrease can lead to changes in the ES 
cells differentiation processes, I have differentiated into neurons shNS-ES and 
shKlf7-ES stable clones. The major finding was an evident two-days delay in 
neurites formation in Klf7-silenced cells (fig.11c). Moreover, when the Klf7-
silenced ES cells were induced to differentiate into cardiomyocytes from EBs, 
there was a dramatic decrease in the beating capacity of cardiomyocytes (fig. 
11b). 
 
Figure 11: Klf7 silencing in ES cells. 
(a) Western blot show KLF7 and ACTIN protein levels in ES cells stably transfected with shNS or 
shKlf7 vectors. (b) Beating ability of cardiomyocytes generated from shNS or shKlf7 stably 
transfected ES cells. Data are expressed as percentage of beating on total EBs. Asterisk represents 
p ≤ 0.01 when compared to control cultures (ANOVA, Scheffè F-test).  (c) Neurites outgrowth in 
shNS or shKlf7 stably transfected ES cells following neuronal induction. Images represent cells 
after 8 days of neuronal induction. 
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3.3.1 KLF7 expression analysis following Oct4 and Nanog gene silencing. 
 
To further analyse KLF7 potential role in ES cells, I have investigated also the 
possible link between KLF7 and stemness master genes such as Oct4 and Nanog. 
To this aim I have generated ES stable clones silenced for Oct4 or Nanog, using 
two shRNA expressing vectors included in the same library of the shKlf7 vector. 
Thus I have induced neuronal differentiation shOct4-ES or shNanog-ES stable 
clones, and analysed the Klf7 transcriptional changes. The real time RT-PCR 
analysis showed that in the differentiated cells there was a significant increase of 
Klf7 transcripts (fig.12), suggesting that Oct4 and Nanog may have a repression 
activity on Klf7 transcription. 
 
 
Figure 12: Klf7 expression level following Oct4 or Nanog silencing. 
The diagram shows the relative quantization (mean ± SE) of the Klf7 transcript amplified product 
compared to that of the glyceraldehyde-3-phosphate dehydrogenase (Gapdh, internal standard). 
Data are expressed as ratio Klf7/Gapdh. Analyses were performed in ES cells stably transfected 
with shNS, shNanog or shOct4 vectors as indicated. Asterisks represent p ≤ 0.05 or p ≤ 0,01 when 
compared to the control cultures (ANOVA, Scheffè F-test). 
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3.4 KLF7 role in mesenchymal differentiation. 
The results of ES cells based experiments and KLF7 known role in adipogenesis, 
prompted me to investigate KLF7 possible function in mesenchymal 
differentiation. It is well known that mesenchymal stem cells (MSC) can 
differentiate into adipocytes, condrocytes and osteocytes (Pittenger et al., 1999). 
In order to analyse mesenchymal pathways following KLF7 deprivation, I have 
used the Klf7-KO mice. Unfortunately it is very problematic to generate MSC 
from Klf7-KO mice bone marrow, since they die perinatally, thus I have used 
MEF that can be differentiated into adipocytes and osteocytes (Alexander et al., 
1998; Garreta et al., 2006).  
 
Figure 13: wt and Klf7-KO MEF adipogenic differentiation. 
The upper panels show the Oil Red staining of MEF differentiated into adipocytes. The diagram 
shows the quantification of the lipids droplets deposits after extraction with isopropyl alcohol. 
Asterisk represents p ≤ 0.05 when compared to wt control cultures (ANOVA, Scheffè F-test). 
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First I have differentiated MEF derived from wt and Klf7-KO mice to adipocytes, 
and by Oil red staining, I have shown that Klf7-KO MEF share a significant 
decreased adipogenesis (fig. 13). 
On the contrary when Klf7-KO MEF underwent osteogenic differentiation, have 
shown a slight increase in the Alizarin red staining, proving increased 
osteogenesis (fig. 14). 
 
 
 
Figure 14: wt and Klf7-KO MEF osteogenic differentiation. 
The upper panels show the Alizarin Red staining of MEF differentiated into osteocytes. The 
diagram shows the quantification of calcium deposits after extraction with guanidine-HCl. 
Asterisk represents p ≤ 0.05 when compared to wt control cultures (ANOVA, Scheffè F-test). 
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3.5 KLF7 role in NSC.  
 
Previous published works proved with in vivo expression data and KO 
characterization experiments that KLF7 is involved in the nervous system 
development, but it is not known if it is important for the NSC biology. To this 
aim I have analysed the self-renewal and differentiation skills of wt and Klf7-KO 
neurospheres, derived from newborn mice.  
To investigate KLF7 possible role in NSC self-renewal, I have performed a 
neurosphere assay on wt and KO cultures. Thus I have cultured a small number of 
neurospheres in 96 multiwell plates (see material and methods) and counted every 
week the number of neurospheres generated. After 4 weeks I have not found any 
significant difference in the rate of neurospheres expansion between wt and KO 
samples (fig. 15). 
 
 
 
 
Figure 15: Self-renewal ability in wt and Klf7-KO neurospheres. 
The diagram shows the result of neurospheres assay. Neurospheres have been passed and counted 
each week.  
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In parallel I have evaluated the differentiation potential of the wt and Klf7-KO 
dissociated neurospheres into the three neural lineages, namely, neurons, 
astrocytes and oligodendrocytes. The immunocytochemical analysis have not 
shown any evident difference in the amount of cells positive for neuronal 
(βTUBB3), glial (GFAP) or oligodendroglial (NG2) markers after 9 days in 
culture (fig. 16). 
 
 
 
 
Figure 16: wt and Klf7-KO neurospheres differentiation. 
The panels show immunocytochemical staining on for βTUBB3, GFAP or NG2 on dissociated 
neurospheres after 9 days of differentiation. The cells nuclei have been stained with DAPI. 
 
 
 
 Subsequently I have analysed proliferation markers such as Ki67 that marks all 
mitotically active cells, pospho-HISTONE 3 that highlights only cells in M phase 
of mitosis, BLBP that is present in all neurogenic regions during brain 
development and the NSC intermediate filament nestin. Ki67, pospho-HISTONE 
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3 and nestin immunostaining, did not show differences between wt and Klf7-KO 
samples, whereas I show that Klf7-KO cells share a significant decrease in the 
BLBP positive fraction (fig. 17a,b). Thus I have confirmed by western blot 
analysis that BLBP protein levels were decreased in the Klf7-KO neurospheres 
derived cells both after 1 day and after 9 days in culture (fig. 17c).  
 
 
 
 
 
Figure 17: BLBP protein expression in wt and Klf7-KO neurospheres. 
(a) BLBP immunohistochemical analysis of dissociated neurospheres after 1 day in culture. The 
cells nuclei have been stained with DAPI. (b) Quantification of BLBP+ cells. Data are expressed 
as ratio BLBP+/DAPI+ cells. Asterisk represents p ≤ 0,0505 when compared to wt control cultures 
(ANOVA, Scheffè F-test). (c) BLBP western blot analysis of dissociated neurospheres after 1 day 
or 9 days in culture.  
 
 
In order to understand if the BLBP positive cells overlapped with other NSC 
markers (nestin, GFAP), I have performed a double staining for BLBP and these 
CHAPTER 3 – RESULTS                                                                                     48  
markers, and as it is deductible from the figure 18 both NESTIN and GFAP 
positive cells were much less than those BLBP positive; moreover in all samples 
analysed there was not consistent colocalization of BLBP with either NESTIN or 
GFAP and no evident differences among wt and KO samples. Thus in 
neurospheres culture BLBP marks a population wider than NSC.  
Finally, by real time RT-PCR analysis, I have found that a Blbp deficit is present 
also in vivo, at least in Klf7-KO OB (fig. 19). 
 
 
 
 
 
Figure 18: BLBP+ cells immunocytochemical analysis. 
The panels show the double immunocytochemical staining for BLBP/NESTIN or BLBP/GFAP. 
BLBP is marked with a rhodaminated secondary antiboby, whereas NESTIN and GFAP are 
marked with a fluorescinated secondary antibody. The cells nuclei have been stained with DAPI. 
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Figure 19: BLBP transcriptional analysis in newborn brain tissues. 
The diagram shows the relative quantization (mean ± SE) of the Blbp transcript amplified product 
compared to that of the Hypoxanthine phosphoribosyltransferase (Hprt, internal standard). Data 
are expressed as ratio Blbp/Hprt. Asterisk represent p ≤ 0.05 when compared to the wt control 
cultures (ANOVA, Scheffè F-test). 
 
 
 
 
3.6 KLF7 role in dopaminergic system development. 
 
Ramirez group has shown by in situ experiments, that during CNS development, 
Klf7 mRNA is clearly expressed in the ventral Mb between E11,5 and E16,5, that 
is the same time window in which crucial events for dopaminergic neurons 
development take place. Thus I have further analysed by real time RT-PCR Klf7 
expression during ventral Mb ontogenesis in wt mouse. This experiment has 
shown that Klf7 transcription has a peak between E13,5 and E15,5 that is 
consistent with a putative role in the development of the Mb dopaminergic system 
(fig. 20).  
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Figure 20: Klf7 expression during mouse ventral midbrain ontogeny. 
The diagram shows the relative quantization (mean ± SE) of the Klf7 transcript amplified product 
compared to that of the Hypoxanthine phosphoribosyltransferase (Hprt, internal standard). Data 
are expressed as ratio Klf7/Hprt. Additional abbreviations: postnatal day (P), adult stage (AD). 
 
 
 
Subsequently to perform a wider characterization of KLF7 role during CNS 
ontogenesis, I have dissected various brain tissues (cortex, OB, ventral Mb, 
hippocampus, rombencephalon and spinal cord) from E11,5 to P0 stage derived 
from wt and Klf7-KO mice.  These tissues have been analysed by real time RT-
PCR with a set of primers for markers of specific neuronal populations and 
generic markers of  development (table 2).  
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Table 2: List of markers analysed in wt and Klf7-KO brain tissues. 
Each of the listed markers have been analysed by real time RT-PCR in E11,5; 
E13,5; E15,5 and P0 wt and Klf7-KO brain tissues. 
 
 
 
The major findings of the transcriptional analysis have been a significant decrease 
of Th and Dat both in the ventral Mb and in the OB of newborn Klf7-KO mice. To 
further analyse if there was a deficit in the differentiation phase of the 
dopaminergic development, I have also evaluated the expression levels in the 
ventral Mb of two TFs essential for DA development, Nurr1 and Pitx3 and I have 
not found any significant difference between wt and Klf7-KO samples. Also 
GABAergic (Gad1, Gad2) and glutamatergic (Eaat1) markers, have not shown 
any transcriptional change in the Klf7-KO samples both in the ventral Mb and OB 
when compared to wt siblings (fig. 21a,b). 
 
CATEGORY MARKERS 
PRO-NEURAL Mash1,Ngn1, Ngn1, Neurod 
GABAERGIC Dlx2, Dlx5, Gad1, Gad2, Gat1, Gat2, Gat3, Gat4, 
Vgat, Gabat. 
DOPAMINERGIC Th, Dat, Nurr1, Pitx3, Vmat2, Lmx1a, Lmx1b, Msx1, 
Foxa1, Foxa2, En1, En2, Gdnf, Drd1, Drd2, Drd3, 
Drd4, Drd5. 
NORADRENERGIC Phox2a, Dbh. 
SEROTONERGIC Sert, Tph1, Tph2. 
GLUTAMATERGIC Eaat1. 
OTHERS Map2, Mecp2, Ret, Uncx4.1, Bdnf, TrkA, Otx2, 
Cacna1a, Cacna1b, Oct4, Nanog. 
CHAPTER 3 – RESULTS                                                                                     52  
 
 
Figure 21: Transcriptional characterization of wt and Klf7-KO ventral Mb and OB. 
The diagrams show the relative quantization (mean ± SE) of the Th, Dat, Eaat1, Gad1 and Gad2 
transcripts amplified product compared to that of the Hypoxanthine phosphoribosyltransferase 
(Hprt, internal standard). The analyses were performed on newborn ventral Mb (a) or OB (b). 
Data are expressed as ratio Th/Hprt. Dat/Hprt, Eaat1/Hprt, Gad1/Hprt or Gad2/Hprt. Asterisks 
represent p ≤ 0.05 or p ≤ 0,01 when compared to the wt control cultures (ANOVA, Scheffè F-test). 
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In order to assess the dopaminergic deficit in the Klf7-KO brain, I have performed 
TH immunohistochemical analysis on sagittal brain slices of newborn mice. TH 
immunostaining highlighted that in the Klf7-KO, there is a lighter expression in 
the ventral Mb, and a drastically impaired signal in the fibers projecting to the 
striatum (fig. 22). 
Therefore I have confirmed that KLF7 deprivation during development leads to 
an impairment of the dopaminergic system, that is particularly evident in the 
striatum.
 
Figure 22: TH immnunohistochemical analysis on wt and Klf7-KO brain. 
The panels show TH immunohistochemical staining on sagittal sections. Mb&Striatum and OB 
images magnification is respectively 2,5x and 5x. The arrows indicate the orientation of the 
sections: rostral (R), caudal  (C), dorsal (D), ventral (V).
CHAPTER 4 – DISCUSSION                                                                               54  
 
 
 
 
 
CHAPTER 4 
DISCUSSION 
 
 
 
 
 
 
 
CHAPTER 4 – DISCUSSION                                                                               55  
4 DISCUSSION 
 
In my PhD project I have studied KLF7 functions both with in vitro and in vivo 
approaches.  
My in vitro experiments have been focused on KLF7 role in cellular 
differentiation. To this aim I have analysed the possible effects of KLF7 depletion 
on distinct differentiation processes. Considered that during development Klf7 is 
mainly expressed in the nervous system and that it is essential for neuronal 
development and maintenance in the mouse CNS (Laub et al., 2001, 2005), I have 
focused my attention predominantly on neuronal differentiation. Thus I have 
performed Klf7 RNAi on both the neuronal cell line PC12 and ES cells, and 
analysed the effects on neuronal markers transcripts or neurite outgrowth.  
Downregulation of Klf7 gene expression in PC12 results in a substantial reduction 
of Map2 and TrkA transcripts. MAP2 is a well-known hallmark of neuronal 
differentiation both in vivo and in vitro (Dehmelt and Halpain, 2004). Thus it is 
likely that Klf7 activity may affect Map2 gene expression by direct or indirect 
action. Also TrkA mRNA strongly decreases following stable silencing of Klf7 
gene expression in PC12 cells. It is well known that PC12 cells differentiate into 
neurons via stimulation of TRKA, following NGF treatment (Chao at Hempstead, 
1995). Moreover this finding is consistent with previously published results 
showing that KLF7 may activate TrkA transcription in vitro, and that in Klf7-KO 
mice there is loss of TRKA(+) sensory neurons (Lei et al. 2001, 2005). 
Klf7 silenced ES cells that undergo neuronal induction, share a two days delay in 
neuronal differentiation, suggesting that KLF7 action is crucial for the right 
timing of neurites outgrowth. Moreover Oct4 or Nanog silencing by RNAi causes 
a Klf7 transcriptional increase in ES cells differentiated into neurons. Thus it is 
likely that Klf7 is negatively regulated by Oct4 and Nanog, that is in accordance 
with published data showing that Klf7 overexpression in ES cells leads to a 
differentiated morphology and Nanog down-regulation, and that Klf7 is a 
potential downstream target of OCT4 and NANOG (Loh et al., 2006, Ivanova et 
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al. 2006). 
The potential KLF7 involvements in ES cells self-renewal mechanisms prompted 
me to analyse self-renewal and differentiative properties of Klf7-KO derived 
NSC. The neurosphere assay has not shown significant differences between wt 
and Klf7-KO NSC behaviour, but the immunocytochemical and western blot 
analysis have revealed that the Klf7-KO neurospheres share a BLBP protein 
deficit. It is interesting to note that BLBP is expressed in the neonatal RMS 
(Hartfuss et al., 2001) as well as Klf7, and that in Klf7-KO mice there is an 
evident impairment in the periglomerular layer of the OB, where the neuronal 
precursors migrating through the RMS differentiate into interneurons (Guillemot 
and Parras, 2005). Thus it is conceivable that, in Klf7-KO mice, BLBP deficit 
may alter the normal NSC migration along the RMS, during brain development. 
Further in vivo BrdU labeling experiments could clarify this hypothesis. 
In order to enrich the functional profile of KLF7 in cellular differentiation, I have 
also tested its role in other biological processes, such as cardiogenesis, 
adipogenesis and osteogenesis. Intriguingly I have found that Klf7 silenced ES 
cells are strongly impaired to differentiate into cardiomyocytes, whereas in Klf7-
KO MEF there is an impairment in adipogenic and an increase in the osteogenic 
differentiation.  
Thus in vitro, KLF7 seems to have a flexible role in the balance between 
pluripotency and differentiation induction, depending on the cellular context. A 
putative example, already mentioned, is that in ES cells OCT4 and NANOG need 
to repress Klf7 expression in order to maintain the undifferentiated state.  
Another interesting hypothesis about KLF7 role in cellular differentiation is the 
regulation of mesenchymal pathways. Indeed my experiments show that KLF7 
depletion may affect the balance between adipogenesis and osteogenesis in MEF. 
In contrast with the finding of other groups (Kanazawa et al. 2005, Kawamura et 
al. 2006) showing that Klf7 overexpression in preadipocytes inhibits adipogenesis, 
I find that Klf7-KO MEF share impaired adipogenesis. The possible explanation 
to this apparent contradiction is that during mesenchymal differentiation 
processes any alteration in the proper KLF7 protein amount can mislead the 
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differentiative pathways. It is not known if in vivo KLF7 is crucial for the 
regulation of mesenchymal differentiation. Regarding adipogenesis, a partial 
answer may come from a recently published work that has identified in the Klf7 
promoter a single nucletotide polimorphysm that has a protection role against 
obesity (Zobel et al., 2009). 
By in vivo analyses, I have focused my attention on the potential KLF7 role in 
dopaminergic system development. Klf7 expression in the developing mouse 
ventral Mb was initially proved by in situ experiments (Laub et al., 2001). Thus I 
have performed a transcriptional characterization of Klf7 during mouse ventral 
Mb ontogenesis. The result highlights a peak in Klf7 transcription between E13,5 
and E15,5 suggesting that its expression is needed to fulfil the proper 
differentiation program of ventral Mb neurons. Moreover the transcriptional 
analysis of the Klf7-KO newborn brain has revealed that dopaminergic markers 
such as Th and Dat are impaired both in ventral Mb and OB. The dopaminergic 
deficit in Klf7-KO brain has been further confirmed by immunohistochemical 
analysis, that also show an impairment of TH protein expression in the nigro-
striatal pathway. It is remarkable that I have not found any transcriptional 
alteration in Nurr1 and Pitx3 expression levels, therefore it is likely that KLF7 is 
not involved in the differentiation phase of dopaminergic neurons, but rather in 
the maintenance of the dopaminergic phenotype. It is intriguing the hypothesis 
that in the Klf7-KO OB, the dopaminergic and BLBP deficits could be linked. 
Indeed the OB dopaminergic neurons derive from neuroblasts migrating along the 
RMS. Considering also the cortex misprojection defects and the L1cam deficit in 
the Klf7-KO brain (Laub et al., 2005, Kajimura et al., 2006), it is likely that in 
vivo, Klf7 role in neuronal morphogenesis is involved in the proper neuronal 
migration and axonal guidance. The latter are indispensable for the correct 
neuronal maturation and target recognition, that in turn are crucial for the neurons 
maintenance and survival. This is well documented for DA neurons (Smidt and 
Burbach, 2007). 
Thus understanding of KLF7 functions may be useful to better comprehend the 
mechanisms that underlie nervous system developmental processes. Among these, 
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the maintenance of the dopaminergic phenotype, specially in the nigro-striatal 
pathway, seems to be affected by KLF7 expression, suggesting a potential 
involvement in a neurodegenerative disease such as PD. 
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